DrugDashboards

Potassium Chloride

potassium chloride · POTASSIUM CHLORIDE 8 meq/1 · Tablet, Film Coated, Extended Release · Oral · Mylan Pharmaceuticals Inc.

NDC 00378-4560-77 · 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

22 companies supply this market — deep enough that no single failure threatens the supply. The generic price is down 27% over the past year, to $0.1020 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1020per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.0412per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.2051per TABweighted avg manufacturer price $0.0624 · Aug 1, 2019201% of what pharmacies pay — higher than 86% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4Oct 2014Sep 2026$0.102
142 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$3.06
#90 count
$9.18

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$9,312
776 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

8● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 28% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for potassium chloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $24.12 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Xywav and Xyrem

Regulatory

Application
ANDA204662
TE code
AB2
Approval date
Aug 21, 2014
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-01)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-11)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-15)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-01)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-11)Jul 23, 2025
  • Planned discontinuation — Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-15)Jul 23, 2025
  • Planned discontinuation — Potassium Chloride, Tablet, Extended Release, 600 mg (NDC 0832-5322-10)Jul 23, 2025
  • Planned discontinuation — Potassium Chloride, Tablet, Extended Release, 600 mg (NDC 0832-5322-11)Jul 23, 2025
  • Planned discontinuation — Potassium Chloride, Tablet, Extended Release, 750 mg (NDC 0832-5323-10)Jul 23, 2025
  • Planned discontinuation — Potassium Chloride, Tablet, Extended Release, 750 mg (NDC 0832-5323-11)Jul 23, 2025

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of potassium chloride (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 3, 2026
Upsher-Smith Laboratories, LLCPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 3, 2026
Upsher-Smith Laboratories, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsPOTASSIUM CHLORIDE 10 meq/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdPOTASSIUM CHLORIDE 1125 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LtdPOTASSIUM CHLORIDE 1500 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
AvKAREPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCPOTASSIUM CHLORIDE 750 mg/1Aug 26, 2026Sep 2, 2026
Epic Pharma, LLCPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.POTASSIUM CHLORIDE 8 meq/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.POTASSIUM CHLORIDE 10 meq/1Jul 15, 2026Sep 2, 2026
NCS HealthCare of KY, LLC dba Vangard LabsPOTASSIUM CHLORIDE 1500 mg/1Jul 15, 2026Sep 2, 2026
NCS HealthCare of KY, LLC dba Vangard LabsPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.POTASSIUM CHLORIDE 1500 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.POTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Slate Run Pharmaceuticals, LLCPOTASSIUM CHLORIDE 600 mg/1Jul 15, 2026Sep 2, 2026
Slate Run Pharmaceuticals, LLCPOTASSIUM CHLORIDE 1500 mg/1Jul 15, 2026Sep 2, 2026
St. Mary's Medical Park PharmacyPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Sep 2, 2026
Northwind Health Company, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Aug 31, 2026
Slate Run Pharmaceuticals, LLCPOTASSIUM CHLORIDE 750 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Potassium Chloride — NDC 00378-4560-77," retrieved September 3, 2026, https://drugdashboards.com/drug/00378456077.

Free to cite with attribution — see how the data is put together.